Economy

Highlights Portfolio Strategy Firming operating metrics, a capex upcycle, rock bottom valuations and deeply oversold conditions all suggest that it no longer pays to be bearish Big Pharma. Upgrade to neutral, today. A looming M&A boom, excess liquidity leaking into biotech stocks, extremely pessimistic Wall Street analysts’ forecasts and severe undervaluation, all suggest that now is the time to go against the grain and overweight biotech equities. Recent Changes Lift the S&P pharmaceuticals index to neutral and remove it from the high-conviction underweight list cementing gains of 12.6% and 10.3% respectively. Boost the S&P biotech index to overweight today. Both of these moves also lift the S&P health care sector to an above benchmark allocation. Table 1 Feature The bulls have taken full control of the equity market and propelled almost every index to fresh all-time highs despite a muted earnings season. Not only are the SPX, the DOW industrials and transports, the NASDAQ composite and the NASDAQ 100 all flirting with uncharted territory, but also more obscure indexes like the Value Line Arithmetic (gauging the average US stock) and Geometric (gauging the median US stock) indexes have also cleared the all-time high bar (Chart 1). On a stock level, bellwether AAPL – the largest stock in the world – has yet to make the leap to new highs despite a blowout profit report and gargantuan buyback announcement, which is cause for near-term concern. Given that the Fed orchestrated this once in a lifetime bonanza, it is also the Fed that can spoil this party, at least temporarily, by removing the proverbial punchbowl. Peering toward the back half of the year, our view remains that the Fed will have to relent and taper asset purchases as inflation will be rearing its ugly head not in a transitory, but more on a semi-permanent fashion. Importantly, the USD can further fan this inflationary impulse. Chart 2 shows that US real GDP expectations are trouncing the rest of the world (ROW) as we first showed in early March. Similarly the ISM manufacturing dichotomy compared with the ROW PMIs is as good as it gets. While this would typically call for a surge in the greenback, counterintuitively we think the path of least resistance is lower for the US dollar as the US economy reaches an inflection point versus the ROW mid-year. Crudely put, if the USD merely ticked up on such a wide economic differential, once Europe and Japan play catch up as the vaccine rollouts and economic reopening smoothen up, then investors will likely flee the US dollar. Chart 1All Time Highs Everywhere Chart 2Relative Growth Expectations At A Zenith With regard to stock market dynamics, this is welcome news for revenue growth, especially for internationally sourced SPX sales that garner a 40% share of total revenues. Since the US dollar floated in the early 1970s, the inverse correlation has increased between top line S&P 500 growth and the greenback (Chart 3). The implication is that a US dollar debasing from current levels will further boost the allure of companies that can raise selling prices. On that front our Corporate Pricing Power Indicator (CPPI) that we recently updated has been on a tear, underscoring that sales growth will soon follow suit (Chart 4). Chart 3Depreciating USD A Boon For SPX Sales Chart 4Rising Inflation Will Boost Revenues Tack on optimistic Chief Executives, and the picture brightens further for SPX revenue prospects. Inflation breakevens also corroborate the messages from our soaring CPPI and surging business confidence (Chart 4). One level down to the SPX GICS1 sector level, Charts 5, 6 & 7 highlight sales growth expectations, with deep cyclicals reigning supreme –especially the energy complex– and defensives the clear laggards (all sectors are compared with the broad market). On the early cyclical front, consumer discretionary equities are forecast to grow sales by 500bps more than the SPX, while financials are slated to trail the overall market by 500bps. Chart 5Consumer Discretionary… Chart 6…And Deep Cyclicals… Chart 7…Have The Upper Hand With regard to the contribution to SPX sales growth for calendar 2021, Table 2 details sector sales growth, sector sales weight, all ranked by sector contribution to SPX sales growth. Chart 8 highlights that consumer discretionary, energy and health care comprise roughly half of the increase in overall revenue growth for 2021. Adding industrials and tech to the mix and these five sectors explain 80% of this year’s projected top line growth contribution to the SPX. Table 2SPX GICS1 Sector Sales Analysis Chart 8Sector Contribution To 2021 SPX Sales Growth Drilling further into industry sub-groups and for inclusion purposes, Table 3 shows our universe of coverage, ranking GICS1 sectors by 12-month forward sales growth and then re-ranking by sub-groups always from highest-to-lowest. Table 3Identifying S&P 500 Sector Sales Growth Leaders And Laggards Circling back to investment implications and gelling everything together, what should investors do given this backdrop? If portfolio managers can stomach volatility and sail through the seasonally weak month of May, then holding the line and sitting tight is the appropriate strategy. However, if investors cannot stomach the bout of volatility that is likely looming, then playing some defense would make sense. We stand closer to the latter camp, and this week we take profits on a defensive group and lift exposure to neutral and boost another beaten down health care sub-group to overweight. These two moves also lift the S&P health care sector to an above benchmark allocation. Exiting The ER The bearish undertones haunting the S&P pharmaceuticals index are well ingrained in investors’ minds and our portfolio has also handsomely benefited from avoiding this key health care industry group. However, it no longer pays to be negative Big Pharma and today we book gains of 12.6% and lift exposure to neutral, and also take this index out of our high-conviction underweight list locking in gains of 10.3% since the early December inception. Chart 9 shows that likely all the adverse news is priced in rock bottom valuations and extremely oversold technical conditions. In fact, the pharma forward P/E ratio is trading at a 40% discount to the SPX and all time low since the GICS reclassification of sectors took place in the early 1990s! While such drubbing is warranted, as this defensive index has to contend an economy exiting recession and also a near unanimous outcry against industry pricing power gains, the easy money has been made on the short/underweight side. This de-rating has coincided with a collapse in relative forward profit growth, on a 12-month and five-year basis, both of which are probing all-time lows (Chart 10). The implication is that the EPS bar is so low it is nearly guaranteed that Big Pharma will surpass it. Such extreme pessimism is contrarily positive and if there is even a whiff of positive profit news, an explosive rally will take root. Chart 9Unloved And Under-owned Chart 10Analysts Have Given Up On Pharma Encouragingly, our macro EPS growth models signal that pharma profits have a strong pulse and will outshine the overall market in the coming year (Chart 11). We recently highlighted the near perfect inverse correlation of the relative share price ratio with the US leading economic indicator and the US ZEW. Similarly, we have shown in the recent past that a number of subcomponents of the ISM manufacturing survey also move inversely with pharma relative profitability. Now that the ISM is at a zenith, staying bearish pharmaceutical stocks will likely prove offside. Meanwhile, Chart 12 shows that the fed funds rate impulse is neither contracting nor weighing on relative share prices. Similarly, the bond market has already priced in two hikes in two years, warning that the relative share price ratio risk/reward tradeoff is slowly shifting to the overweight column. Chart 11Out Of The Ward On the operating front, Big Pharma is investing anew with capex gone parabolic (bottom panel, Chart 13). The last time pharma capital outlays rose over 20%/annum was in the early 1990s! Chart 12There Is A Pulse Chart 13Capex To The Rescue? Industry shipments are climbing roughly at a double digit clip and pharma output is also expanding smartly, underscoring that soon industry productivity will also ascend, which is a boon for profits (Chart 14). Tack on the export relief valve pharma manufacturers are enjoying of late, and factors are falling into place for an earnings led rebound in pharma equities (second panel, Chart 14). Finally, the top panel of Chart 15 highlights that demand for pharmaceuticals in as upbeat as ever and has been significantly diverging from relative share prices. The implication is that this steep gulf will narrow via a catch up phase in the latter. Chart 14Glimmers Of Hope Chart 15Upbeat Demand, But Deflation Is A Tough Pill To Swallow Nevertheless, before getting outright bullish this heavyweight health care sub-group, there are two significant (and related) offsets. Industry pricing power is under attack and will remain in duress until it reaches a new equilibrium (middle panel, Chart 15). As a result, pharmaceutical profit margins have been in an almost uninterrupted multi year squeeze, warranting only a neutral allocation to Big Pharma manufacturers, until these dark profit clouds clear (bottom panel, Chart 15). Netting it all out, firming operating metrics, a capex upcycle, rock bottom valuations and deeply oversold conditions all signal that it no longer pays to be bearish Big Pharma. Upgrade to neutral, today. Bottom Line: Crystalize gains in the S&P pharma index of 12.6% since inception and lift exposure to neutral. We are also removing it from the high-conviction underweight list locking in gains of 10.3% since inception. The ticker symbols for the stocks in this index are: BLBG: S5PHARX– JNJ, PFE, MRK, LLY, BMY, ZTS, CTLT, VTRS, PRGO. Buy Biotech Stocks Against The Grain We recommend investors buy the budding recovery in biotech stocks, and today we are boosting the S&P biotech index to an above benchmark allocation. Rising interest rates have dampened demand for biotech stocks as these high growth stocks should command a lower multiple on the back of a rising discount rate (top panel, Chart 16). Add on waning US dollar liquidity and the relative underperformance phase gets explained away (bottom panel, Chart 16). However, there still remains a sizable gap between relative profits and relative share prices. If our four-pronged bullish thesis that we detail below pans out, then a catch up phase looms in crushed biotech stocks (Chart 17). Chart 16Bearish Story Well Documented Chart 17Peculiarly Wide GapFirst, we posit that this highly fragmented industry is prime for consolidation. Even in the large cap S&P 500 biotech index there is scope for M&A activity. Not only intra-industry mergers, but also cash rich and drug pipeline extension thirsty Big Pharma is lurking in the shadows ready to deploy their cash hoard. Already, there is an ongoing mini M&A boom and given the recent biotech firms’ success stories in the race to discover the COVID-19 vaccine, they command a high profile in investment banking board rooms (Chart 18). Second, as long as the Fed remains committed to ZIRP and margin debt balances continue to balloon, some of this excess liquidity will flow toward biotech stocks that are more speculative than their safe-haven health care brethren. Historically, relative margin debt balances and relative share prices have been joined at the hip, and the message from spiking margin debt uptake is to expect a similar rebound in biotech equities (Chart 19). Chart 18M&A Boom Is Bullish Chart 19Speculative Excesses Go Hand-In-Hand With Biotech Stocks Third, the sell side has thrown in the towel on the prospects of the S&P biotech index. Relative sales growth expectations are negative, relative 12-month and five-year forward growth numbers are sinking like a stone and probing all-time lows (Chart 20). All this analyst pessimism is gaining steam at a time when the S&P biotech dividend yield is 2.5%, roughly 100bps higher than the 10-year US Treasury yield and 125bps higher than the SPX dividend yield (bottom panel, Chart 20). Finally, not only the relatively large dividend yield gap signals that biotech stocks are cheap, but on a forward P/E basis the S&P biotech index trades at a whopping 50% discount to the SPX (fourth panel, Chart 20). Our Valuation Indicator has collapsed to levels that have marked prior bull phases going back 25 years and similarly technicals are as downbeat as ever (Chart 21). Chart 20Low Threshold To Overcome Chart 21Cheap And Oversold In sum, a looming M&A boom, excess liquidity leaking into biotech stocks, extremely pessimistic Wall Street analysts’ forecasts and severe undervaluation, all signal that now is the time to go against the grain and overweight biotech equities. Bottom Line: Lift the S&P biotech index to overweight, today. This upgrade along with the S&P pharma upshift to neutral also lift the S&P health care sector to overweight. The ticker symbols for the stocks in this index are: BLBG: S5BIOTX– AMGN, ABBV, GILD, VRTX, REGN, ALXN, BIIB, INCY.       Anastasios Avgeriou US Equity Strategist anastasios@bcaresearch.com   Current Recommendations Current Trades Strategic (10-Year) Trade Recommendations Size And Style Views February 24, 2021 Stay neutral cyclicals over defensives January 12, 2021  Stay neutral small over large caps June 11, 2018 Long the BCA Millennial basket  The ticker symbols are: (AAPL, AMZN, UBER, HD, LEN, MSFT, NFLX, SPOT, ABNB, V). January 22, 2018 ​​​​​​​Favor value over growth

Highlights Sweden’s economic recovery is robust and will deepen. Policy is accommodative. Very few advanced economies will benefit as much from the global economic rebound. The labor market will tighten, capacity utilization will increase, and inflation will rise faster than the Riksbank forecasts. On a one- to two-year investment horizon, the SEK is a buy against both the USD and the EUR. Despite their pronounced outperformance, Swedish stocks possess significantly more upside against both Eurozone and US equities over the remainder of the cycle. Swedish industrials will beat their competitors in both these markets. Nonetheless, China’s policy tightening creates a meaningful tactical risk, which selling Norwegian stocks can hedge. Italy’s fiscal plan constitutes a new salvo in Europe’s efforts to avoid last decade’s mistakes. Feature Last week, the Swedish Riksbank did not follow in the footsteps of the Norges Bank. The Swedish central bank acknowledged that the economy is performing better than anticipated and that the housing market is gaining in strength; yet, it refrained from hinting at any forthcoming adjustment to its policy rate or the pace of its asset purchase program. The positive outlook for the Swedish economy will force the Riksbank to tighten policy significantly before the ECB. As a result, we expect the Swedish Krona to outperform the euro and the US dollar. Moreover, investors should continue to overweight Swedish equities due to their large exposure to industrials and financials, even if they have already significantly outperformed the Euro Area. Sweden’s Economic Outlook The Swedish economy will accelerate, which will put pressure on resource utilization and fan inflationary risk in the years ahead. The degree of stimulus supporting Sweden is consequential. Chart 1A Dual Labor Market On the fiscal front, the government support measures that have been announced since the beginning of the COVID-19 crisis currently amount to SEK420bn, or SEK197bn for 2020 (4% of GDP), and SEK223bn for 2021 (4.5% of GDP). Moreover, generous labor market protection and part-time employment schemes meant that the number of employees in permanent employment contracts remained stable during the pandemic (Chart 1). Thus, the bulk of the rise in Swedish unemployment came from workers on fixed-term contracts. Monetary policy remains very accommodative as well. The Riksbank left its repo rate unchanged at 0% through the crisis, but cut its lending rate from 0.75% to 0.1%. More importantly, the Swedish central bank is aggressively injecting liquidity into the economy. It set up a SEK500bn funding-for-lending facility in order to incentivize bank lending to the nonfinancial private sector, and started a SEK700bn QE program, which as of Q1 2021 had purchased SEK380bn securities and which will purchase another SEK120bn in Q2, with covered bonds issued by banks accounting for 70% of it. As a result, the amount of securities held on the Riksbank balance sheet will nearly triple by year end (Chart 2). Chart 2The Riksbank Is Open For Business Beyond the monetary and fiscal stimulus, many factors point to greater economic strength for Sweden. Despite a slow start to the process, as of last week, nearly 30% of the Swedish population had received at least one vaccine dose, which is broadly in line with vaccination rates prevalent in France or Germany. Crucially, the pace of vaccination is accelerating at a rate of 13% per week. Even if this second derivative slows, more than 70% of the population will have received at least one dose by this summer. Thus, greater mobility is in the cards during the second quarter, which will boost household spending. Chart 3The Wealth Effect The housing market also favors a pick-up in consumption. The HOX housing price index is growing at a 15% annual rate, its fastest expansion in over 5 years. As a result of the wealth effect, this rapid appreciation is consistent with a swift improvement in the growth rate of household expenditures (Chart 3). Moreover, spending on durable goods now stands 1.3% above its pre-pandemic levels, while spending on non-durables is back to pre-pandemic levels. This context suggests that increased mobility translates into greater spending. The industrial sector remains a particularly bright spot in the Swedish economy. Sweden is extremely sensitive to the global industrial and trade cycle, because exports represent 45% of GDP. Moreover, the highly cyclical intermediate and capital goods comprise 56% of the country’s foreign shipments, which accentuates the beta of the Swedish economy. BCA Research remains optimistic about the global industrial cycle. Sweden will reap a significant dividend. Already the Swedish PMI points to stronger industrial production, and the index’s exports component is roaring ahead (Chart 4). The potential for a greater uptake in consumption, capex, and durable goods spending in the rest of the EU (Sweden’s largest trading partner) bodes well for the Swedish manufacturing sector. Additionally, if the collapse in the US inventory-to-sales ratio is any indication for the rest of the world, a global restocking cycle is forthcoming, which will further boost Swedish industrial activity (Chart 4, bottom panels). Finally, global public infrastructure plans are on the rise, which will also help Sweden. Chart 4Sweden Is well Placed Chart 5Brightening Labor Market Prospects In this context, the Swedish labor market should tighten significantly in the approaching quarters. Already, job vacancies are rebounding, and redundancy notices have normalized, which matches both the GDP growth surprise in Q1 and the continued rise in the NIER Sweden Economic Tendency Indicator. Furthermore, the employment component of the PMIs stands at 58.9 and is consistent with a sharp improvement in job growth over the coming year (Chart 5). The expected labor market growth will contribute to an increase in capacity utilization, which will place upward pressure on wages and inflation. When the 12-month moving average of US and Eurozone imports rises, so does the Riksbank Resource Utilization Indicator, because global trade has such a pronounced effect on the Swedish economy (Chart 6). Meanwhile, greater resource utilization leads to accelerated inflation, greater labor shortages, and rising unit labor costs (Chart 7).  Chart 6CAPU Will Rise Chart 7The Coming Pressure Buildup Bottom Line: As a result of generous stimulus and the global economic recovery, the Swedish economy is set to continue its rebound. Consequently, employment and capacity utilization will improve meaningfully, which will lead to a resurgence of inflation and wages in the coming 24 months. Investment Implications On a 12 to 24 months horizon, we remain positive on the Swedish krona and Swedish equities. Fixed Income And FX Chart 8Three Hikes By 2025 The backend of the Swedish OIS curve only discounts 75bps of hikes by 2025. This pricing is too modest (Chart 8). The Swedish economy will rebound further as the vaccination campaign advances, and rising house prices and household indebtedness will fan growing long-term risk to financial stability, both of which suggest that the Riksbank will have to change its tack in 2022. The great likelihood that the Fed will start tapering off its asset purchase toward the end this year, that the ECB will follow sometime in 2022, and that the Norges Bank will be increasing interest rates next year will give more leeway to the Swedish central bank. A wider Sweden/Germany 10-year government bond spread is not an appealing vehicle to play a more hawkish Riksbank down the road. This spread hit a 23-year high in March and now rests at 62bps or its 98th percentile since 2000. Moreover, the terminal rate proxy embedded in the German money market curve is currently so low that the spread between Sweden’s and the Eurozone’s terminal rate proxy stands near a record high. Hence, German yields already embed much more pessimism than Swedish ones. Nonetheless, BCA recommends a below benchmark duration exposure within the Swedish fixed-income space, as we do for other government bond markets around the world.1 A bullish bias toward the SEK is a bet on the Riksbank that offers a very appealing risk/reward ratio, according to BCA Research’s Foreign Exchange Strategy strategists.2 The krona is very cheap against both the euro and the US dollar, trading at 9% and 29% discounts to purchasing power parity, respectively. Moreover, the Swedish current account stands at 5.2% of GDP, compared to 2.3% and -3.1% for the Euro Area and the US, creating a natural underpinning under the SEK. Chart 9The SEK Loves Growth Over the coming 12 to 24 months, cyclical forces favor selling EUR/SEK and USD/SEK on any strength. The SEK is one of the most cyclical G-10 currencies and has one of the strongest sensitivities to the US dollar. Hence, our positive global economic outlook and our FX strategists negative view on the greenback are synonymous with a weak USD/SEK. These same factors also mean that the krona will appreciate more than the euro, as the negative correlation between EUR/SEK and our Boom/Bust Indicator and global earnings growth illustrate (Chart 9). Equities We also like Swedish equities, but the state of the Swedish economy and the evolution of the Riksbank policy surprise have a limited impact on Swedish equities. The Swedish bourse is mostly about the evolution of the global business cycle. The Swedish benchmark heightened sensitivity to the global business cycle reflects its massive overweight in deep cyclicals, with industrials, financials, consumer discretionary, and materials accounting for 38.4%, 26.1%, 9.7% and 3.7% of the MSCI index respectively, or 78% altogether (Table 1). As a result, BCA’s preference for global cyclicals at the expense of defensives and this publication’s fondness for the recovery laggards like the industrial and financial sectors automatically translate into a favorable bias toward Sweden’s stocks.3 Table 1Mamma Mia! That’s A Lot Of Cyclicals Valuations offer a more complex picture, but they do not diminish our predilection for Sweden. Swedish equities trade at a discount to US stocks but at a premium to Euro Area ones (Chart 10). However, Swedish stocks offer higher RoEs and profit margins than both the US and the Euro Area, while also sporting lower leverage (Chart 11). Thus, their valuation premium to Euro Area stocks is warranted and their discount to US ones is excessive, especially when rising yields hurt the relative performance of the growth stocks that dominate US indexes. Chart 10Swedish Discounts And Premia Chart 11Profitable Sweden The outlook for Swedish earnings is appealing, both in absolute and relative terms. The Swedish market’s extreme sensitivity to global economic activity means that Sweden’s EPS increase and beat US profits when the Riksbank Resource Utilization Indicator expands (Chart 12). These relationships are artefacts of the Swedish economy’s pro-cyclicality, which causes capacity utilization to interweave tightly with the global business cycle (Chart 6). Chart 12The Winner Takes It All Chart 13Better Capex Play Than You Global capex and infrastructure spending favor Swedish equities compared to Euro Area ones. Over the past thirty years, Sweden’s stocks have outperformed those of the Eurozone when capital goods orders in the advanced economies have expanded (Chart 13). This reflects the Swedish benchmark’s large overweight in industrials, a sector that is the prime beneficiary of global capex. Capital goods orders are recovering well, and their growth rate can climb higher, especially as western multinationals announce capex plans and as governments from the US to Italy intend to ramp up infrastructure spending. Moreover, the large pent-up demand for durable goods in the Eurozone further enhances the potential of industrial firms, and thus, of Swedish equities.4  Chart 14Another Sign Of Pro-Cyclicality BCA Research’s positive cyclical stance on commodities offers another reason to overweight Sweden’s market relative to that of the US and the Euro Area. Our Commodity and Energy Strategy sister service anticipates significant further upside for natural resources, especially base metals, over the remainder of the business cycle.5 Commodity prices still have room to rally, because demand will grow as the global economy continues to recover and because the supply of natural resources has been constrained by a decade of low investment. As a result, rising metal prices will symptomatize strong economic activity around the world and will incentivize capex in commodity extraction, both of which will boost the revenue of industrial firms. Furthermore, commodity price inflation often corresponds with rising yields, which boosts financials as well. These relationships explain the Swedish stocks’ outperformance of US and Eurozone stocks, when natural resource prices rally, despite the former’s low exposure to materials (Chart 14). At the sector level, the appeal of Swedish industrials relative to those of the Eurozone and the US completes the rationale to favor Swedish equities in a global portfolio. Swedish industrials are just as profitable as US ones and are more so than Euro Area ones, while having significantly lower leverage than either of them (Chart 15). Additionally, for the past two years, the EPS growth of Swedish industrials has bested that of US and Eurozone ones. Yet, their forward P/E ratio trades in line with the US and the Euro Area, while the sell-side’s long-term relative earnings growth estimate is too depressed (Chart 16). The same observations are valid when comparing Swedish industrials to French or German ones. Hence, in the context of a global business cycle upswing, buying Swedish industrials while selling their US and Euro Area competitors is an appealing pair trade, especially since it also involves short USD/SEK and short EUR/SEK bets. Chart 15Attractive Swedish Industrials... Chart 16...And Not Expensive Despite our optimism toward Swedish stocks on a 12 to 24 months basis, investors must hedge a near-term risk. Chinese authorities are aiming to contain financial excesses and trying to restrain credit growth. As we showed four weeks ago, China’s excess reserve ratio is contracting, which points toward a slowdown in the Chinese credit impulse.6 Historically, such a development can hurt global cyclicals, and thus, also Swedish equities. However, BCA Research’s China strategists believe that Beijing will not kill off the Chinese business cycle; thus, the recent disappointment in the Chinese PMI is transitory.7   Chart 17Industrials vs Materials: Europe vs China Materials more than industrials will suffer the brunt of a China slowdown, as the re-opening trade and capex cycle among advanced economies will create a buffer for the latter. Indeed, the performance of global industrials relative to materials stocks correlates with the evolution of the spread between the Euro Area and Chinese PMI (Chart 17). Thus, we recommend selling Norwegian equities to hedge the tactical risk inherent in an overweight on Sweden. As Table 1 above shows, Norway overweighs materials and energy (two sectors greatly exposed to China), hence, a temporary pullback in commodity prices should hurt Norwegian stocks more than Swedish ones. Bottom Line: The SEK is an inexpensive and attractive vehicle to bet on both the global business cycle strength and the Swedish economic recovery. Thus, investors should use any rebound in EUR/SEK and USD/SEK to sell these pairs. Moreover, Swedish stocks greatly overweight cyclical sectors, particularly industrials and materials. This sectoral profile renders Swedish equities as attractive bets on the global economy. Additionally, Swedish shares display alluring operating metrics. As a result, we recommend investors go long Swedish industrials relative to those of the US and Euro Area. They should also overweight Swedish equities against the US and the Eurozone. Consequent to some China-related tactical risks, an underweight stance on Norwegian stocks constitutes an attractive hedge to this Swedish exposure. A Few Words On Italy’s National Recovery And Resilience Plan Mario Draghi’s plan to revive the Italian economy, announced last week, is an important marker of Europe’s changing relationship with fiscal policy. Last decade, excessive austerity contributed to subpar growth, ultimately firing up concerns about debt sustainability in many peripheral economies, and fueled risk premia in Italy and Spain. Under the cover of the current crisis, and in the face of the changing political winds in Brussel and Berlin where fiscal rectitude is not the mantra it once was, national European governments are beginning to propose ambitious fiscal stimulus plans. The National Recovery and Resilience program illustrates these dynamics. The EUR248bn plan is a testament to the importance of the NGEU recovery program as well as the REACT EU recovery fund. Through these facilities, the EU will contribute EUR191.5bn to the fiscal plan via grants and loans. Italy will contribute the remainder of the funds. While the total amount disbursed over the next six years corresponds to 14% of Italy’s 2019 GDP, the Draghi government estimates that the program will add 3.2 percentage points to GDP between 2024 and 2026. Importantly, markets are not rebelling. Despite expectations that Italy would continue to run an accommodative fiscal policy, the BTP/Bund spreads remain stable. We can expect this trend of greater stimulus to be mimicked around the EU. Spain is another large recipient of the NGEU program, and it too is likely to increase stimulus beyond what the EU will fund. France will hold an election in May 2022, and President Macron has all the incentives to stimulate the economy between now and then. If, as we wrote last week, Germany shifts to the left in September, then this outcome will be guaranteed. Bottom Line: The Draghi plan is the first salvo of greater fiscal stimulus in the EU. This trend will help Eurozone growth improve relative to the US over the coming few years. Despite a loose fiscal policy, BTPs and other peripheral bonds will continue to outperform on the back of declining risk premia.   Mathieu Savary, Chief European Investment Strategist Mathieu@bcaresearch.com   Footnotes 1Please see Global Fixed Income Strategy “GFIS Model Bond Portfolio Q1/2021 Performance Review & Current Allocations: Grand Reopening,” dated April 6, 2021, available at gfis.bcaresearch.com 2Please see Foreign Exchange Strategy “2021 Key Views: Tradeable Themes,” dated December 4, 2020, available at fes.bcaresearch.com 3Please see European Investment Strategy “Summer Of ‘21,” dated March 22, 2021, available at eis.bcaresearch.com 4Please see European Investment Strategy “Winds Of Change: Germany Goes Green,” dated April 23, 2021, available at eis.bcaresearch.com 5Please see Commodity & Energy Strategy “Industrial Commodities Super-Cycle Or Bull Market?” dated March 4, 2021, available at ces.bcaresearch.com 6Please see European Investment Strategy “The Euro Dance: One Step Back, Two Steps Forward,” dated March 29, 2021, available at eis.bcaresearch.com 7Please see China Investment Strategy “National People’s Congress Sets Tone For 2021 Growth,” dated March 17, 2021, available at cis.bcaresearch.com Cyclical Recommendations Structural Recommendations Currency Performance Fixed Income Performance Government Bonds Corporate Bonds Equity Performance Major Stock Indices Geographic Performance Sector Performance Closed Trades

Highlights Last week featured a lot of good news for financial markets and the economy … : US GDP grew at 6.4% in the first quarter, powered by 10.7% growth in consumption; the six largest companies in the S&P 500 reported first quarter earnings that exceeded expectations by an average of 41%; and the Fed remained resolutely dovish. … and we continue to believe that they are likely to remain in our “just-right” base-case scenario over the next twelve months … : Our Goldilocks base-case scenario is underpinned by strong growth and accommodative monetary policy. Strong growth is assured as long as the virus doesn’t come roaring back, and the Fed still isn’t even talking about talking about tapering its asset purchases, much less hiking the fed funds rate. … so our risk-friendly asset allocation recommendations remain unchanged: There are no signs yet that equities and credit will not continue to generate significant excess returns over Treasuries and cash over the next twelve months. Feature We will be holding a webcast next Monday, May 10th at 10:00 a.m. Eastern time in lieu of publishing a Weekly Report. Please join us with your questions to make it a fully interactive event. We will resume our regular publication schedule on the 17th. Some say the world will end in fire, Some say in ice. – Robert Frost, “Fire and Ice”   We continue to view financial markets and the economy through the lens of our stylized Goldilocks-and-the-Two-Tails distribution (Figure 1). Though the figure gives short shrift to our subjective probability that the Goldilocks base-case scenario will unfold over the next twelve months (≈ 70-75%), and overstates the likelihood of a too-cold outcome (≈ 5-10%), the size of the too-hot right tail (≈ 20-25%) is roughly in line with our expectations. Last week’s spate of economic data, company earnings releases and Fed guidance supported our view and shored up our conviction in it. The twin pillars of well-above-trend growth and extremely accommodative monetary policy remain firmly in place. Figure 1Goldilocks And The Two Tails Last week’s data were especially strong. Sticking to the highlights, and skipping the uncertain impacts of the measures President Biden floated before a joint session of Congress, the following items suggest that the just-right scenario is considerably more probable than not. The Conference Board’s consumer confidence index surged higher (Chart 1, top panel) and given the way it tends to track the jobs plentiful sub-index (Chart 1, bottom panel), the road ahead looks good, provided that job openings rise as businesses still operating at limited capacity ramp up their operations. We have not found that consumer confidence is a robust predictor of key economic series, but the advance supports the notion that several elements are falling into place. Chart 1Consumer Confidence Is Surging ... Initial jobless claims for the week ended April 23rd made their third straight post-pandemic low and the four-week moving average extended its recent descent (Chart 2). The four-week moving average is poised to take another step lower next week once the 742,000 April 2nd reading falls out of the calculation (the last three weeks have averaged 568,000). Headline first-quarter GDP growth of 6.4% was strong, albeit just shy of consensus expectations, but the underlying details were better. Adjusting for the 2.6-percentage-point drag from inventory destocking, which will turn into a boost when inventories are replenished in the future, and backing out the 0.9-percentage-point trade deficit, real final domestic demand surged at an annualized rate of 9.9%. Chart 2... And Layoffs Are Steadily Falling On the corporate earnings front, the six largest S&P 500 constituents, Apple, Microsoft, Amazon, Google, Facebook and Tesla, all reported earnings that easily surpassed consensus expectations (Table 1). Those six companies account for 23% of aggregate index market cap and their beats drove projected per-share first-quarter earnings more than 7% higher, from $42.69 to $45.83. Even if the reports were not necessarily greeted by share-price gains, they have the index poised to deliver a fourth consecutive earnings beat of outsized proportions (Chart 3). Although the biggest companies’ successes in the calendar first quarter cannot blindly be extrapolated into the future, they suggest that S&P 500 earnings over the next four quarters will be greater than the market expected before last week. The beat goes on. Table 1Lifting All Boats Chart 3Four Straight Quarters Of Eye-Popping Beats The Fed Maintains Its Poker Face While the FOMC acknowledged that the economy has strengthened since its mid-March meeting, it showed no inclination to accelerate its timetable for dialing back accommodation. Though all four of the tweaks to its mid-March statement amounted to a marginal upgrade of its assessment of the economy’s current state and/or prospects, Chair Powell held fast to his messaging and the committee stayed the course on asset purchases. We continue to take the Fed at its word that it will not hike rates until the economy passes its “three tests” and it will not begin to taper asset purchases until it judges that the economy has made "substantial progress" toward meeting them. The picture has surely improved, but the inflation and employment criteria are not yet within reach. To recap, the Fed’s three preconditions for hiking the fed funds rate are as follows: 12-month PCE inflation must be 2% or higher. Labor market conditions must have reached levels consistent with maximum employment. 12-month PCE inflation must be on track to moderately exceed 2% for some time. Whether or not the economy has made substantial progress toward meeting those criteria is a squishier concept and the Fed has already given itself pre-emptive discretion on the first and most objective criterion by saying it will look through any transitory factors that push measured inflation higher. Powell called out base effects from last year’s pandemic wipeout that will disappear by June. He also cited supply-chain bottlenecks, and while he conceded that it is much harder to predict when they will be resolved, the committee is certain that they will prove to be a temporary phenomenon as well. “Full employment” is also a subjective metric, but the quarterly Summary of Economic Projections, released after every other FOMC meeting, provides a ready proxy. Our US Bond Strategy colleagues have calculated the average monthly net payroll gains required to reach the low end, the midpoint and the high end of the range of the participants’ long-run unemployment rate estimates, which currently span 3.5% to 4.5%, under various labor force participation rate assumptions (Tables 2A, 2B and 2C). We are focused on the top row of each iteration of the table because only a return to the pre-pandemic labor force participation rate of 63.3% would seem to satisfy the Fed’s stated commitment to achieving broad-based employment gains. While a return to the 3.5% pre-pandemic unemployment rate would also be consonant with spreading the gains from the expansion most broadly, it is useful to consider the full range of plausible outcomes given the Fed’s desire to retain some decision-making flexibility. Table 2AAverage Monthly Nonfarm Payroll Growth Required For The Unemployment Rate To Reach 4.5% By The Given Date Table 2BAverage Monthly Nonfarm Payroll Growth Required For The Unemployment Rate To Reach 4% By The Given Date Table 2CAverage Monthly Nonfarm Payroll Growth Required For The Unemployment Rate To Reach 3.5% By The Given Date Per our colleagues’ simple assumptions, it would require an average of anywhere from 701,000 to 833,000 monthly net payroll additions to hit full employment by the end of the year, 534,000 to 631,000 by the middle of 2022, and 410,000 to 487,000 by the end of 2022. The year-end 2021 targets are probably too ambitious, but we think the economy can return to full employment at some point next year, given that labor demand will likely rise sharply upon the release of pent-up consumption demand. As a back-of-the-envelope check on the tables’ conclusions, we take a return to pre-pandemic employment as the goal for a return to full employment. Through March, 8.3 million fewer people were employed than at the pre-pandemic peak in December 20191 (Chart 4). It would take fourteen months (May 2022) to regain full employment at an average monthly pace of 600,000 net hires or seventeen months (August 2022) to achieve that goal at a 500,000-per-month clip. Chart 4More Than 8 Million Workers Still Don't Have A Job A 500,000-to-600,000 range seems doable to us if herd immunity can be achieved before the end of the summer and we expect that the economy will return to full employment somewhere around the middle of next year. That will position the Fed to hike rates for the first time in 2022, in line with the market’s December 2022 lift-off projection, and announce the start of tapering at the end of 2021 or the beginning of 2022. Those Fed views support our recommendations to maintain below-benchmark duration within fixed income portfolios and underweight Treasuries. Press Conference Highlights Jay Powell stayed on message at the post-meeting press conference, resisting every attempt to goad him into revealing more about the tapering timetable or expressing concern about the pickup in inflation and inflation expectations or the economy’s potential to overheat following unprecedentedly large fiscal stimulus. On Tapering Direct questions about tapering bookended the press conference and Powell batted them away directly and concisely. Opening question: Is it time to start talking about talking about tapering yet? A: No, it is not time yet. We’ll give the public plenty of notice when it is. Final question: What are we getting for $120 billion [of Treasury and agency purchases each month] that we couldn’t get for less? A: There will come a time to talk about talking about tapering. That time is not now. On Inflation (And Armchair Quarterbacks) The combination of strong fiscal support and the reversal of a synchronized (and unprecedented) global economic shutdown has the economy beginning to move ahead with potent momentum. The re-opening is likely to produce increases in inflation but we are fully cognizant that they are likely to be temporary. While we are not going to adjust monetary policy unnecessarily in response to temporary inflation pressures, we do not want inflation expectations “materially above” 2% and we will use our tools to bring them down if they were to reach those levels. Our commitment to our price stability mandate is the key difference between now and the late sixties and seventies and we’re well aware of the history of that period. On Transitory Inflation Factors Base effects are going to add about one percentage point to headline and 70 basis points to core inflation in April and May. They will disappear and “carry no implications for the rate of inflation in later periods.” Bottlenecks are a temporary blockage or restriction in the supply chain that slows down the process of delivering a good or bringing it to market. We think of them as things that will naturally be resolved as businesses and individuals adapt. They therefore do not call for a change in monetary policy even if it’s difficult to predict when they will disappear. For the bottlenecks, it’s “a matter of when they will pass through, not whether they will pass through.” What’s happening to prices now is a function of the re-opening of the economy. Demand, spurred by fiscal transfers and people going back to work, has come back much more quickly while the supply side will take a little bit of time to adapt. On Overheating/Bubbles The overall financial stability picture is mixed, but we view it as manageable on balance. There’s some froth in capital markets and strong home price appreciation is not an “unalloyed good,” but the housing market is much more stable than it was before the crisis. Leverage in the financial system is not a problem, the large banks are very well capitalized and don’t have any funding issues and households are in very good shape. Investment Implications Although our conviction levels are lower against a backdrop of unprecedented fiscal stimulus and the inherent uncertainty surrounding a global pandemic, we continue to hold to our view that overheating is unlikely in the near term. The output gap has still not closed and while households have an enormous amount of dry powder in the form of what we estimate to be $2.1 trillion of excess savings, some of 2020’s foregone services demand has been lost forever. The share of foregone demand that has been deferred rather than destroyed will not be released immediately and may well be spread out over a broad range of price points where there is available capacity (think flying business instead of coach, sitting in the best seats at the stadium or the theater, or ordering more expensive bottles of wine). Most importantly on the inflation front, broad wage pressures have not yet emerged. As Chair Powell noted, if the labor market really were tightening, one would expect wages to be rising. We expect that idled workers will return to the labor force as vaccinations proceed, schools reopen and the pandemic becomes less of an impediment to working. We are skeptical that the $300 weekly federal unemployment insurance benefit supplement is having a material effect on labor force participation, but the program will cease in September in any event. Chart 5Neither TIPS Inflation Break-Evens ... Chart 6... Nor CPI Swap Inflation Break-Evens Are Sounding The Alarm Our biggest inflation concern revolves around long-term inflation expectations. As long as economic actors like workers and businesses do not believe the long-run trajectory of consumer prices has changed, they have no reason to change their behavior to demand wage and price increases to keep pace with an upward inflection in the CPI. The slope of the two-to-five-year and five-to-ten-year segments of the inflation expectations curve remain negative (Charts 5 and 6), suggesting that the inflation mindset necessary to support an upward price spiral has not taken hold. We will not worry about the risk-asset bull market’s fiery demise until the 2-year/5-year and 5-year/10-year break-even slopes start to test the top of their post-GFC range, implying that investors believe a new inflation era has arrived.   Doug Peta, CFA Chief US Investment Strategist dougp@bcaresearch.com Footnotes 1 Per the household survey. The monthly employment situation report also includes the establishment survey of employers. We use the household survey here because it is used to calculate the unemployment rate though the establishment survey’s 8.4-million employment shortfall is nearly equivalent to the household survey's.

Highlights The kiwi will continue to benefit from a pandemic-free recovery and normalization in monetary policy from the RBNZ. However, the kiwi is becoming expensive according to most of our models. This will begin to impact growth via the trade channel. For the rest of the year, the NZD/USD could hit 75 cents, but will likely underperform other developed market currencies. Feature Chart I-1NZD And Relative Economic Growth New Zealand has been one of the few countries to get the COVID-19 pandemic under control in short order. Since June of last year, the number of new infections has been practically zero. The vaccination program is lagging most other developed countries, but the authorities expect most citizens will be inoculated by the end of this year. The travel bubble with Australia has opened up the service sector to a recovery that remains the envy of most other developed economies. The New Zealand dollar has responded in tandem with the improvement in domestic conditions (Chart I-1). While the USD is up this year, NZD has still appreciated by about 1% against the dollar. From the March lows last year, the kiwi is up 22%, only trailing the Australian dollar and Norwegian krone within the G10. In this report, we explore the outlook for the kiwi, looking at key drivers such as the pandemic, the commodities boom, and the prospect for monetary policy amidst a hot housing market. In our view, the NZD still faces upside, but less so than other developed market currencies. A Robust Recovery Together with Singapore and Australia, Bloomberg ranks New Zealand as one of the safest places to be during the pandemic. This has allowed the manufacturing PMI in New Zealand to hit fresh highs, easily surpassing very robust activity in the US. Relative economic performance between New Zealand and its trading partners has tended to define the trend in the currency. The services sector is still trailing behind, as most of the world remains under lockdown (Chart I-2). However, a travel bubble has opened up with Australia, and it is fair to assume that service-sector activity is a coiled spring ready to rebound, especially as tourism constitutes a non-negligible share of New Zealand GDP (Chart I-3). Chart I-2A Recovery In Services Underway Chart I-3Tourism Will Boost NZ GDP Employment in New Zealand has already seen a sizeable recovery. The unemployment rate hit 4.9% in December, very close to the Reserve Bank of New Zealand’s (RBNZ) own estimate of NAIRU. Next week’s release should show an even more robust rebound. Inflation remains well contained at 1.5%, but as the economy begins to bump against supply-side constraints, this should change. The quarterly employment survey showed that wages are rising at a 4% clip. Eventually, a labour market that has fully recovered, burgeoning inflationary pressures and an economy open for business will mean the need for the RBNZ to maintain emergency monetary policy settings will be eliminated. A Terms-Of-Trade Boom While the domestic economy has benefited from strong government support, and very accommodative monetary policy settings, the external environment has also provided a gentle tailwind for the New Zealand economy. Over the last few decades, one of the key primary drivers of the NZD exchange rate has been terms of trade. New Zealand’s top exports are predominantly in agricultural commodities. Strong export growth has boosted the trade balance, both in volume and price terms (Chart I-4). An increasing trade balance naturally means that NZDs are being buffeted with demand. China has led the pack in imports from New Zealand vis-à-vis other countries by simple virtue of the fact that the authorities started injecting stimulus much earlier on, which helped ease domestic financing conditions. China is also New Zealand’s biggest export market. While the credit impulse in China is set to slow this year, demand for foodstuffs is less sensitive compared to demand for other higher-beta commodities. This will support New Zealand exports. At the same time, there has been a supply component to the boom in agricultural commodity prices. Adverse weather has impacted the planting season for many agricultural goods. As a result, stock-to-use ratios have begun to roll over, particularly in some of the goods that New Zealand exports (Chart I-5). This is likely to reverse, as farmers take advantage of higher prices and increase productivity. Chart I-4A Terms Of Trade ##br##Boom Chart I-5Falling Stocks Have Boosted Agricultural Prices In a nutshell, the outperformance of the kiwi has been a combination of supply shocks in the agricultural market, and an economy that has had an impressive rebound. Going forward, the kiwi should continue to do well versus the dollar as economic momentum picks up. The Housing Mandate Housing prices in New Zealand have been on a tear (Chart I-6). As a result, the government has mandated that house price considerations be tied into monetary policy decisions. The direct implication of this is that interest rates in New Zealand are set to increase. In the coming months, the labor market mandate for the RBNZ is about to become a lot tougher, because of the opposing forces between financial and economic stability. Tightening monetary policy too fast and too soon will expose the economy to a potential relapse in growth. But allowing housing prices to continue to become unaffordable for most residents is both politically untenable and economically unsustainable. The end game is likely to be as follows: The RBNZ will be quick to tighten monetary policy on domestic grounds and housing market concerns. This will provide a further boost to the kiwi. Yields in New Zealand are already among the highest in the G10, which will only accelerate with tighter monetary conditions. By the same token, the Chinese economy will likely slow as the credit impulse is peaking. This means New Zealand domestic growth will become more important for the NZD than external conditions. Countries with relatively easier monetary policy will see some benefit. Particularly, the Reserve Bank of Australia might lag the RBNZ. If this eventually benefits the Aussie economy, it might hurt the AUD/NZD cross now, but might make way for fresh long positions later (Chart I-7). Chart I-6A Housing Market Boom Chart I-7Where Next For AUD/NZD? Historically, housing prices in New Zealand have correlated quite strongly with the exchange rate. If the RBNZ is successful in engineering lower housing prices, it will also succeed in weakening the NZD (Chart I-8). Chart I-8House Prices And The Kiwi We were stopped out of our long AUD/NZD trade last week for a modest profit of 2.3%. We are standing aside for the time being, but will be buyers of the cross at 1.05. This will likely be realized towards the end of this year when optimism on the kiwi is likely to peak. How High Can The NZD Bounce? Another reason why the rise in the NZD might soon face strong upside resistance is valuation. Usually, a rise in the NZD over a cycle goes uninterrupted until the cross becomes expensive. On this basis, the kiwi might soon peak. Our purchasing power parity (PPP) models point to a 10% overvaluation in the New Zealand dollar (Chart I-9) versus the USD. Chart I-9The NZD Is Expensive One of our favorite metrics for the kiwi’s fair value is its real effective exchange rate relative to its terms of trade. On this basis, the New Zealand dollar is around fair value. On a longer-term real effective exchange rate basis (REER), the kiwi is 7.4% expensive, or 0.7 standard deviation above the mean (Chart I-10). Chart I-10The NZD Is Expensive The equity market in New Zealand looks particularly vulnerable. Heavily weighted in defensive sectors, this bourse will be particularly vulnerable to a rise in yields that will derail potential equity inflows (Chart I-11). Chart I-11Kiwi Stocks Are Expensive Chart I-12CHF/NZD Could Rise With Volatility Another opportunity is to buy the CHF/NZD cross, which looks attractive at current levels (Chart I-12). Should markets experience some form of turbulence, the cross will benefit. Meanwhile, CHF/NZD just dipped to the upward sloping trend line that has dictated support levels for this cross since 2007. Thus, we recommend investors initiate a long position in CHF/NZD.   Chester Ntonifor Foreign Exchange Strategist chestern@bcaresearch.com Currencies U.S. Dollar Chart II-1USD Technicals 1 Chart II-2USD Technicals 2 The data out of the US were mildly positive this week. Quarter-on-quarter annualized GDP growth came in at 6.4% in Q1, rising from 4.3% in the previous quarter. Initial jobless claims fell to 553K in the week ended April 23, from 566K the previous week. Consumer Confidence for April came in at 121.7 beating the expected 113. The S&P/Case-Shiller House Price Index rose 11.9% year-on-year in February. Fed maintained the target range for the Fed Funds rate at 0 to 0.25%. The US dollar DXY index was flat this week. Although the dollar advanced earlier in the week with treasury yields posting small gains, it weakened on Wednesday ahead of the Fed meeting. Compared to the record-breaking preliminary PMIs of last Friday, milder data this week and the dovish tone of the Fed aren’t helping the downward trend of the dollar. Report Links: Arbitrating Between Dollar Bulls And Bears - March 19, 2021 The Dollar Bull Case Will Soon Fade - March 5, 2021 Are Rising Bond Yields Bullish For The Dollar? - February 19, 2021 The Euro Chart II-3EUR Technicals 1 Chart II-4EUR Technicals 2 Recent euro area data have been soft. The IFO Business Climate Index inched up only 0.2 points to 96.8 and disappointed expectations of a much more significant increase to 97.8.  The BNB Business Barometer of Belgium surprised to the upside and jumped to a decade high of 4.4 from a revised 1.04. The German GfK Consumer Confidence contracted to -8.8 for May and the French Consumer Confidence stayed the same in April. The euro strengthened by 0.5% against the US dollar this week. The uneven data out of Europe reflects differences in COVID restrictions throughout the region. Tighter measures were announced in some German regions and Belgium is easing restrictions. However, overall, we remain optimistic on the outlook for the entire region as the accelerating vaccination effort should support the economy reopening this summer. We are long EUR/CHF. Report Links: Relative Growth, The Euro, And The Loonie - April 16, 2021 Portfolio And Model Review - February 5, 2021 On Japanese Inflation And The Yen - January 29, 2021 The Japanese Yen Chart II-5JPY Technicals 1 Chart II-6JPY Technicals 2 The data out of Japan was scant this week. Bank of Japan maintained interest rates at -0.1%. Retail Sales in March grew 5.2% year-on-year, beating forecasts of 4.7%. The Japanese yen weakened by 0.5% this week. Due to the current state of emergency throughout the country, the Bank of Japan is ready to further ease monetary policy as needed and warned of the likelihood for consumption to stay depressed. That said, our intermediate term indicator is hinting at a rebound in the currency. Report Links: The Dollar Bull Case Will Soon Fade - March 5, 2021 On Japanese Inflation And The Yen - January 29, 2021 The Dollar Conundrum And Protection - November 6, 2020 British Pound Chart II-7GBP Technicals 1 Chart II-8GBP Technicals 2 The data out of the UK this week was positive. The Confederation of British Industry (CBI) retail sales volume balance rose to 20 in April from -45 in March, recording the sharpest growth since 2018. The British pound rose by 0.7% against the US dollar this week. The strong retail sales numbers came amidst lockdowns being lifted. While May will continue to see further restrictions eased, cable faces threats from its own success so far this year as well as UK’s recent political turmoil. Also, both the speculative positioning and our intermediate-term indicator are at elevated levels.  Report Links: Portfolio And Model Review - February 5, 2021 The Dollar Conundrum And Protection - November 6, 2020 Revisiting Our High-Conviction Trades - September 11, 2020 Australian Dollar Chart II-9AUD Technicals 1 Chart II-10AUD Technicals 2 The data out of Australia have been soft lately. CPI in Q1 rose 0.6% versus Q4 last year, below the expected 0.9%. The year-on-year growth of 1.1% also undershot the 1.4% forecast. Trimmed mean CPI grew 0.3% on the prior quarter and 1.1% versus a year ago, both failing to beat expectations.  The Q1 export price index rose 11.2% over the prior quarter, compared to the 5.5% rise in Q4. The Australian dollar rose by 1% against the US dollar this week. In addition to both CPI measures disappointing to the downside, a foreseeable peak in the commodity market driven by the slowdown in China can also be a downward drag on the currency especially when the sentiment on the Aussie is elevated. We are short AUD/MXN and were stopped out of our long AUD/NZD trade. Report Links: The Dollar Bull Case Will Soon Fade - March 5, 2021 Portfolio And Model Review - February 5, 2021 Australia: Regime Change For Bond Yields & The Currency? - January 20, 2021 New Zealand Dollar Chart II-11NZD Technicals 1 Chart II-12NZD Technicals 2 The data out of New Zealand have been neutral. Trade Balance in March improved by NZD 33M over a month ago and NZD 1690M a year ago.  ANZ business confidence came in at -2 in April, higher than the -4.1 the prior month. The New Zealand dollar strengthened by 1% against the US dollar this week. We discuss the kiwi at length in the front section of this week’s report. The conclusion is that NZD faces near-term upside, but will lag other procyclical currencies over the longer term. Report Links: Portfolio And Model Review - February 5, 2021 Currencies And The Value-Versus-Growth Debate - July 10, 2020 Updating Our Balance Of Payments Monitor - November 29, 2019 Canadian Dollar Chart II-13CAD Technicals 1 Chart II-14CAD Technicals 2 The data out of Canada this week continue to be positive. Both Retail Sales and Core Retail Sales in February grew 4.8% over the prior month, comfortably exceeding the expectations of 3.7% and 4% growth, respectively. The Canadian dollar rose 0.8% against the US dollar this week. The loonie reacted positively to the strong retail numbers as it continues its path upward on strong inflation data of recent months and a hawkish Bank of Canada. However, even as the COVID case count appears to have peaked, there remains downside risks of very elevated commodity prices and our intermediate-term indicator still just off a recent peak. Report Links: Relative Growth, The Euro, And The Loonie - April 16, 2021 Will The Canadian Recovery Lead Or Lag The Global Cycle? - February 12, 2021 Currencies And The Value-Versus-Growth Debate - July 10, 2020 Swiss Franc Chart II-15CHF Technicals 1 Chart II-16CHF Technicals 2 There was scant data out of Switzerland this week. ZEW expectations for April came in at 68.3, slightly higher than the 66.7 from the prior month. The Swiss franc rose 0.4% against the US dollar this week. While the waning of investors’ sentiment and net speculative positioning may point to some softening in the near term, the recent COVID crisis in India can provide support to this risk-off currency. We are long EUR/CHF. Report Links: Portfolio And Model Review - February 5, 2021 The Dollar Conundrum And Protection - November 6, 2020 On The DXY Breakout, Euro, And Swiss Franc - February 21, 2020 Norwegian Krone Chart II-17NOK Technicals 1 Chart II-18NOK Technicals 2 The data out of Norway this week was positive. Core Retail Sales came in unchanged in March versus the prior month, but beat expectations of a 0.9% decline. The Norwegian krone was 0.8% higher against the USD this week. Norway fits the bill in terms of a post-pandemic boom. New COVID-19 cases are under control, the economy is rebounding, oil prices are strong and the central bank is on a path the raise interest rates this year. Being long the NOK is one of our strongest convictions calls in FX. We are long NOK/USD and NOK/EUR. Report Links: Portfolio And Model Review - February 5, 2021 Revisiting Our High-Conviction Trades - September 11, 2020 A New Paradigm For Petrocurrencies - April 10, 2020 Swedish Krona Chart II-19SEK Technicals 1 Chart II-20SEK Technicals 2 Data out of Sweden this week have been mixed.  The Riksbank maintained the policy rate at 0%. Trade Balance in March came in at SEK4.1B versus SEK6B in the prior month. Retail sales in March grew by 2.6% month-on-month and 9.1% year-on-year, both an improvement versus the prior period. The unemployment rate in March rose to 10% versus 9.7% the prior month. The Swedish Krona strengthened 0.5% against the US dollar this week, continuing its upward momentum throughout April. The recent accommodative signals from the Riksbank meeting were within expectations amidst elevated COVID case counts and restrictions. Despite its commendable gains so far this month, we remain optimistic on this high beta currency as the eurozone recovery and global reflation are in sight. Report Links: Revisiting Our High-Conviction Trades - September 11, 2020 Updating Our Balance Of Payments Monitor - November 29, 2019 Where To Next For The US Dollar? - June 7, 2019 Trades & Forecasts Forecast Summary Core Portfolio Tactical Trades Limit Orders Closed Trades